VSCR special course

17 and 18 April 2023 online

HEALTH ECONOMICS FOR NATIONAL, REGIONAL AND LOCAL HEALTHCARE DECISION MAKING

A guidance for successful discussions and negotiations between Industry and payer organizations

This special course is an elective module of the Diploma program HEALTH OUTCOME RESEARCH-MARKET ACCESS provided by VSCR and the Sigmund Freud University Vienna (SFU).
However, it can be booked also as an independent module on its own as well

SAVE THE DATE VSCR special course_17 and 18 April_2023
Costs:

Regular price: 2,500 euros

Early bird (4 weeks before course start): 1,800 euros

Upon successful assessment (MCQ) a VSCR certificate can be obtained

Registration under office@vscr.at

Course directors and speakers

    • Lieven Annemans, Senior Professor Health Economics, University Ghent, Belgium
    • Heinrich Klech, Professor of Medicine, VSCR, Vienna, Austria
    • N.N.  Key account expert
    • N.N. Corporate affairs expert (optional)

Rationale and Objective

    • Health economic evaluations on a national basis are usually well governed by HE specialists in governmental institutions (HTA), Academia (scientific background/clinical outcomes trial methodology) and Industry (data capture and data presentation of innovations in medicines and medical devices).
    • However, for regional and local evaluations and negotiations with regional and institutional /local payer organizations additional HE capabilities are needed both for industry but also payer authorities. The course will provide understanding of concepts, tools, methods of understanding & building Health Economics evaluations.
    • This VSCR – course focuses on the needed capabilities of non – HE specialists to support efforts for reimbursement not only on national level but even more explicitly also on regional and local level for successful discussions between Industry and regional/local payer organizations or institutional purchase managers.

Target audience:

Industry

      • Key Account Managers
      • Medical Affairs Managers
      • Medical Science Liaisons
      • Sales Managers/Supervisors
      • Marketing Managers
      • Country Managers
      • Regulatory Affairs Managers

Payer institutions

      • Hospital Pharmacists
      • Local/Regional Health Care Institutions Managers
      • Health Insurance House Managers
      • Hospital Managers

Physicians

Draft Program

MODULE I – VALUE BEYOND PRICE

Concept:

Understanding & Representing Value of products – the medical & economic value: use VSCRs health economics training on basic (beginners) level. Key account management does make deals based on cost effectiveness but even more based on budget impact and multicriteria decision analysis (MCDA). So, they need to understand the concepts of Value, Health Economics, HTA, RWE, MCDA & (crucial) Budget Impact

Part 1: Principles of Health Economics/Outcomes Research (HEOR) and Health Technology Assessment (HTA)

THE CONTEXT: Economic foundations and societal background of healthcare decision making based on HEOR and HTA

THE TOOLS:

Evidence Based Medicine (EBM) – Health Outcome Studies – Health Economic Models – Real World Evidence (RWE) – Multi Criteria Decision Analysis – Budget impact analysis

THE PROCESSES

Introduction to the Nature and Principles of HTA

Value and Value for Money from different perspectives

The nature of budget impact analysis

Multi Criteria Decision Analysis (MCDA): pros and cons

LEARNING OBJECTIVES Part 1

At the end of part 1 participants will

  • Understand the present and future challenges for social health care systems
  • Have insights about current strategies to cope with rising costs in health care
  • Understand the impact of data and evidence – based decision making for health care budgets
  • Learn about options how to best prioritize spending in health care budgets both on national and regional level
  • Understand how payers will handle trade-offs in health care spending
  • Learn about the validity of various Health Outcomes studies and the appropriate scenarios to apply
  • Comprehend the need and value of health economic models
  • Comprehend the value and opportunity of RWE and how to use and synthetize them into the present bundle of available (conventional) data
  • Get insight in future aspects of capturing health outcomes data
  • Understand why HTA is a useful process and how it is applied in the context of patient access and health care budget considerations
  • Learn about the concept, the basic principles and the formal process of a HTA
  • Understand the principles and methods of Budget Impact Analysis
  • Understand the principles and methods of MCDA (multicriteria decision analysis)

 

Part 2: From outcome data to value dossiers: an introduction into the basics of successful submissions of dossiers

LEARNING OBJECTIVES Part 2

At the end of part 2 participants will

  • Understand how payers assess technologies depending on their own incentives and setting;
  • See the opportunities in changing payment systems for hospitals and clinicians;
  • Understand the principles and methods of Budget Impact Analysis
  • Understand the need for a tailored yet coherent value story and understand regional economic conditions (e.g. budget impact)
  • See the options about how to deal via agreements with uncertain evidence

MODULE II– THE BUSINESS ACUMEN

Concept: 

  • Critical knowledge and business skills needed for successful market access and management of key accounts
  • Understand & utilize the market access capabilities in concert with supporting functions such as key account management and sales organizations, medical affairs, regulatory, etc.
  • Account planning: planning, strategy, tools for implementation & monitoring
  • Business skills: Alternative Access Schemes or Payer Agreements, complemented by workshops and business cases
  • Basic Financial Concepts
  • Negotiation skills

 Module III“CORPORATE AFFAIRS”

Topics:

Environmental shaping: environment understanding; stakeholder mapping &engagement plans